2025-01-01 2026-01-31 2026-01-31 false 16179671 Repose Healthcare Pending iso4217:GBP xbrli:pure 161796712025-01-01 161796712026-01-31 161796712025-01-01 2026-01-31 16179671bus:Micro-entities2025-01-01 2026-01-31 16179671bus:AuditExempt-NoAccountantsReport2025-01-01 2026-01-31 16179671bus:FullAccounts2025-01-01 2026-01-31 16179671core:WithinOneYear2026-01-31 16179671core:AfterOneYear2026-01-31 16179671core:WithinOneYear2025-01-01 2026-01-31 16179671core:AfterOneYear2025-01-01 2026-01-31 16179671core:CurrentFinancialInstruments2026-01-31 16179671core:Non-currentFinancialInstruments2026-01-31 16179671core:CurrentFinancialInstruments2025-01-01 2026-01-31 16179671core:Non-currentFinancialInstruments2025-01-01 2026-01-31 16179671core:LandBuildings2025-01-01 2026-01-31 16179671core:FurnitureFittings2025-01-01 2026-01-31 16179671core:OfficeEquipment2025-01-01 2026-01-31 16179671core:Vehicles2025-01-01 2026-01-31 16179671core:PlantMachinery2025-01-01 2026-01-31 16179671core:OtherPropertyPlantEquipment2025-01-01 2026-01-31 16179671core:LandBuildings2026-01-31 16179671core:PlantMachinery2026-01-31 16179671core:Vehicles2026-01-31 16179671core:FurnitureFittings2026-01-31 16179671core:OfficeEquipment2026-01-31 16179671core:OtherPropertyPlantEquipment2026-01-31 16179671core:Right-of-useAssets2025-01-01 2026-01-31 16179671core:Right-of-useAssets2026-01-31 16179671core:Goodwill2025-01-01 2026-01-31 16179671core:PatentsTrademarksLicencesConcessionsSimilar2025-01-01 2026-01-31 16179671core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-01-01 2026-01-31 16179671core:OtherResidualIntangibleAssets2025-01-01 2026-01-31 16179671core:Goodwill2026-01-31 16179671core:DevelopmentCostsCapitalisedDevelopmentExpenditure2026-01-31 16179671core:PatentsTrademarksLicencesConcessionsSimilar2026-01-31 16179671core:OtherResidualIntangibleAssets2026-01-31 16179671dpl:CostSales2025-01-01 2026-01-31 16179671dpl:AdministrativeExpenses2025-01-01 2026-01-31 16179671dpl:DistributionCosts2025-01-01 2026-01-3116179671bus:Director12025-01-01 2026-01-3116179671bus:Director22025-01-01 2026-01-3116179671bus:PrivateLimitedCompanyLtd2025-01-01 2026-01-31
Repose Healthcare
Unaudited Financial Statements
for the period ended 31 January 2026
Company registration number 16179671
(England and Wales)

Company Information

For the period 1 January 2025 to 31 January 2026
Directors Mapulanga, Tobias
Parkinson, Clare Meriel

Registered office 1 Skylark Way
Sawston
Cambridge
CB22 3GL

Registered number 16179671

Statement of Financial Position

As at 31 January 2026
2026
£
£
Current assets
11,721
Creditors amounts falling due within one year
(7,424)
Net current assets (liabilities)
4,297
Total assets less current liabilities
4,297
Net assets (liabilities)
4,297
Capital and reserves
4,297

Notes to the Financial Statements

1. Employees

The average number of employees during the year was 0.
The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the Board of Directors on 27 August 2026 and are signed on its behalf by:

Mapulanga, Tobias
Mapulanga, Tobias
Director
Parkinson, Clare Meriel
Parkinson, Clare Meriel
Director

Company registration number 16179671